IBRX280121C00000500
IBRX Jan 21 2028 0.50 Call
optionOPRA
InactiveOct 8, 2026
8.93USD-4.185%(-0.39)2Vol128OI
Loading…
Underlying
Underlying Price
$8.48
Type
Call
Strike
.5
Expiration
Jan 21, 2028
DTE
458d
Moneyness
ITM
Intrinsic
$7.98
IBRX .5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Jan 15, 2027 | 87d | $9.11 | -5.79% | 6 | 720 |
| Jan 21, 2028 | 458d | $8.93 | -4.18% | 2 | 128 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.